Heron Therapeutics Inc HRTX
$0.50
▼ -0.24%
($0.00)
⬇️ Below Yest. Low
🔥 High Short Interest
🗓️ Earnings Next Week
Open
$0.50
Prev Close
$0.50
Day Range
$0.48 – $0.52
52W Range
$0.38 – $1.88
Market Cap
$93.92M
Beta
1.68
EPS (TTM)
$-0.18
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1987-08-26 |
| Shares Out. | 189,280,000 |
| Website | herontx.com/ ↗ |
| Phone | 13026365400 |
| Employees | 128 |
| Revenue | $34.7M |
| Gross Profit | $24.1M |
| Net Income | -$8.1M |
| Free Cash Flow | -$20.9M |
| Total Assets | $246.2M |
| Total Liabilities | $237.1M |
| Equity | $9.1M |
About Heron Therapeutics Inc
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Heron Therapeutics Inc is a publicly traded company under the ticker symbol HRTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
8 analysts (2026-07-01)